Concepedia

Author

Ibrahim Tolaymat

Anglia Ruskin UniversityORCID

Also Known As

I. Tolaymat, Ibrahim Tolaymat

12

Publications

195

Citations

7

H-Index

10

Concepts

All Affiliations

Anglia Ruskin UniversityUniversity of WolverhamptonQatar University
IT

About

Ibrahim Tolaymat is an author at Anglia Ruskin University specializing in drug discovery, medicinal chemistry, and medicine.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

38

2

Pharmacology

2

2

38

3

Drug Discovery

2

2

38

4

Natural Sciences

1

1

21

5

Chemistry

1

1

21

Ibrahim Tolaymat

×

5

Publications

164

Citations

5

H-Index

YearCitations

Development of Injectable PEGylated Liposome Encapsulating Disulfiram for Colorectal Cancer Treatment

Mohammad Najlah, Ammar Said Suliman, Ibrahim Tolaymat,

Pharmaceutics

2019

82

Cyclodextrin Diethyldithiocarbamate Copper II Inclusion Complexes: A Promising Chemotherapeutic Delivery System against Chemoresistant Triple Negative Breast Cancer Cell Lines

Ammar Said Suliman, Mouhamad Khoder, Ibrahim Tolaymat,

Pharmaceutics

2021

27

Efficient synthesis and 5-LOX/COX-inhibitory activity of some 3-hydroxybenzo[b]thiophene-2-carboxylic acid derivatives

Finn K. Hansen, Mehdi Khankischpur, Ibrahim Tolaymat,

Bioorganic & Medicinal Chemistry Letters

2012

21

Preliminary SAR on indole-3-carbinol and related fragments reveals a novel anticancer lead compound against resistant glioblastoma cells

Chris Sherer, Ibrahim Tolaymat, Farzana Rowther,

Bioorganic & Medicinal Chemistry Letters

2017

17

Development, characterization and stability evaluation of ciprofloxacin-loaded parenteral nutrition nanoemulsions

Ammar Said Suliman, Rose Tom, Kirsty Palmer,

Pharmaceutical Development and Technology

2020

17

Page 1